ArticleClinical pharmacokinetics2023

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist.

Islam Younis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.